The restructuring events database contains factsheets with data on large-scale restructuring events reported in the principal national media and company websites in each EU Member State. This database was created in 2002.
Manufacturing (20 - 21) Manufacture of chemicals and pharmaceuticals 21 - Manufacture of basic pharmaceutical products and pharmaceutical preparations 21.2 - Manufacture of pharmaceutical preparations
400 - 500 jobs Number of planned job losses
350 jobs Number of planned job creations
Announcement Date
10 March 2025
Employment effect (start)
10 March 2025
Foreseen end date
31 December 2026
Description
BioNTech, a German biotechnology company, has announced the elimination of 950 to 1,350 full-time positions worldwide BioNTech 2025 - WO by the end of 2027. In Germany, the sites in Marburg (250 to 350 out of a total of 670 jobs) and Idar-Oberstein (around 150 out of 450 jobs) are particularly affected. At the same time, approximately 350 new jobs are expected to be created at the company’s headquarters in Mainz.
The restructuring is driven by a decline in revenue due to falling demand for the Covid-19 vaccine and a significant increase in investment in the development of mRNA-based cancer therapies.
The workforce reduction will mainly occur through redundancies, although job relocations are also planned. No response from social partners has been reported so far.
As of the end of 2024, BioNTech employed approximately 7,200 people worldwide and is currently placing a strong focus on oncological research. The first marketing authorisations for cancer treatments are expected in 2026.
Eurofound (2025), BioNTech, Internal restructuring in Germany, factsheet number 202683, European Restructuring Monitor. Dublin, https://apps.eurofound.europa.eu/restructuring-events/detail/202683.
Eurofound’s ERM restructuring legislation database offers an overview of key restructuring-related regulations in the EU Member States and Norway. Its content is continuously updated to reflect any changes made by national legislators in response to, for instance, policy shifts, legal...
Can Europe still achieve its ambitions for battery manufacturing? To answer this, the article looks at data from Eurofound’s European Restructuring Monitor and explores what recent large-scale restructuring events reveal about the state of play in the EU battery sector.
This working paper offers a comprehensive methodological overview of the European Restructuring Monitor (ERM) databases. Even though the methodology has not changed over time, new categories have been added, and the way it has been used by researchers and policymakers...
This Eurofound research paper explores key trends in restructuring in recent years, highlighting the companies that announced the largest job losses and job gains in the EU. It builds on an analysis of company announcements recorded in Eurofound’s European Restructuring...
In 2023, thousands of workers in big tech lost their jobs. Meta, Amazon, Google, Apple, Microsoft and Salesforce had been considered to offer good and secure jobs up to this point. Giants of the information and communication technology (ICT) sector,...
In 2024, the automotive sector in the EU came to the fore in public and policy discussions. The focus was on the slowdown in electric vehicle (EV) sales, rising global competition, belated investments in new technologies, and the potential closure...